the burden of vte in cancer patients: impacts and novel treatments
Published 6 years ago • 85 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
0:53
the increased risk of thromboembolism in cancer
-
1:02
next steps in vte treatment: will oral edoxoban replace the current standard of care?
-
3:55
the hokusai vte-cancer study: objectives and design
-
6:51
improving quality of vte care
-
2:18
the current landscape of treatment for bpdcn
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
5:03
why this man’s skin turned blue
-
13:27
blood clot update - dvt deep vein thrombosis
-
8:04
dan's story: life with cancer (ddlps)
-
4:15
accurately assessing treatment response in pv and deciding when to switch therapies
-
4:49
clot chronicles: treating vte in cancer
-
2:06
thromboembolic event rates in patients with pv: a real-world analysis
-
1:19
what's on the horizon for the treatment of mpns?
-
30:14
a new look at cancer-associated venous thromboembolism: emerging evidence's influence on guidelines
-
2:29
unmet clinical needs in bpdcn: improving diagnosis and treatment approaches
-
1:02:04
venous thromboembolism in cancer patients - prof. laurent bertoletti (saint-étienne, france)
-
1:39
unmet needs in waldenström’s macroglobulinemia
-
3:36
the real cost of hematological cancer care explained
-
1:38
the risk of bleeding in patients with von willebrand disease hospitalized due to ami
-
2:42
the value of circulating tumor cells for the staging of patients with ndmm
-
1:48
an analysis of transfusion-related cost offsets & time burden in pts with mf in the momentum trial
-
2:32
tools and biomarkers being used for the diagnosis of bpdcn